Genesco (GCO) Tops Q2 EPS by 30c; Lowers FY Outlook
Get Alerts GCO Hot Sheet
Price: $34.55 -3.52%
EPS Growth %: +50.6%
Financial Fact:
Net (loss) earnings: 1.3
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +50.6%
Financial Fact:
Net (loss) earnings: 1.3
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q2 EPS of $0.59, $0.30 better than the analyst estimate of $0.29. Revenue for the quarter came in at $535 million versus the consensus estimate of $549.76 million.
GUIDANCE:
Genesco sees FY2023 EPS of $6.25-$7.00, versus prior of $7.00-$7.75 and the consensus of $7.35. Sales are now expected to be down 3% to flat, compared to FY22, versus prior guidance of up 1% to 3%.
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Braze stock tumbles 10% on weak third quarter EPS guidance
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share